Thiabendazole

Thiabendazole

SCHEMBL30099775

O=PO.c1ccc2[nH]c(-c3cscn3)nc2c1

nearest known ligand 0.83

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
METAP1 P53582 9/20 0.83
METAP2 P50579 7/20 0.83
NPC1 O15118 5/20 0.83
RAB9A P51151 5/20 0.83
SMN1; SMN2 Q16637 5/20 0.83
TP53 P04637 4/20 0.83
KDM4E B2RXH2 3/20 0.83
FKBP1A P62942 2/20 0.83
ADORA3 P0DMS8 2/20 0.83
TSHR P16473 2/20 0.83
CYP1A2 P05177 1/20 0.83
CYP3A4 P08684 1/20 0.83
CYP2D6 P10635 1/20 0.83
CYP2C19 P33261 1/20 0.83
HIF1A Q16665 1/20 0.83
TDP1 Q9NUW8 1/20 0.83
HDAC6 Q9UBN7 1/20 0.83
CA12 O43570 1/20 0.53
CA1 P00915 1/20 0.53
CA2 P00918 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Thiabendazole SCHEMBL675655 1.00 METAP1 (0.83) METAP1METAP2NPC1RAB9ASMN1; SMN2
Thiabendazole SCHEMBL19842 0.91 METAP1 (1.00) METAP1METAP2NPC1RAB9ASMN1; SMN2
Thiabendazole SCHEMBL29370729 0.91 METAP1 (1.00) METAP1METAP2NPC1RAB9ASMN1; SMN2
Thiabendazole SCHEMBL625588 0.91 METAP1 (1.00) METAP1METAP2NPC1RAB9ASMN1; SMN2
Thiabendazole SCHEMBL7733801 0.90 METAP1 (0.97) METAP1METAP2NPC1RAB9ASMN1; SMN2
Thiabendazole SCHEMBL2314460 0.90 METAP1 (0.97) METAP1METAP2NPC1RAB9ASMN1; SMN2
Thiabendazole SCHEMBL28861440 0.90 METAP1 (0.97) METAP1METAP2NPC1RAB9ASMN1; SMN2
Thiabendazole SCHEMBL9856779 0.90 METAP1 (0.97) METAP1METAP2NPC1RAB9ASMN1; SMN2
Thiabendazole SCHEMBL11218788 0.90 METAP1 (0.97) METAP1METAP2NPC1RAB9ASMN1; SMN2
Thiabendazole SCHEMBL5184037 0.90 METAP1 (0.97) METAP1METAP2NPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4109450-A1 INDEPENDENT MULTI-PAGE READ OPERATION ENHANCEMENT TECHNOLOGY Intel Corporation (US) 2022-12-28 EP disclosed